TRUWORTHS INTL RC-,00015/ ZAE000028296 /
30/05/2024 09:10:02 | Var. -0.120 | Volume | Denaro09:52:33 | Lettera09:52:33 | Max | Min |
---|---|---|---|---|---|---|
3.980EUR | -2.93% | 0 Fatturato: 0.000 |
3.640Quantità in denaro: 22,200 | 4.180Quantità in lettera: 19,350 | 4.080 | 3.980 |
GlobeNewswire
10:00
DRCT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Direct Digital Holdings Inc. I...
GlobeNewswire
10:00
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
10:00
EQIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Equinix, Inc. Investors with S...
GlobeNewswire
10:00
CMP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Minerals International,...
GlobeNewswire
10:00
ASTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AST SpaceMobile, Inc. Investor...
GlobeNewswire
10:00
LNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lincoln National Corporation In...
GlobeNewswire
10:00
ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with ...
GlobeNewswire
10:00
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of D...
GlobeNewswire
09:42
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area